New drug combination turbo charges attack against cancer
Survival times have doubled in early testing of this powerful new drug combination for patients with advanced blood cancers.
Researchers identify gene that could lead to better understanding of MDS
Melbourne researchers have uncovered secrets about bone marrow failure that could enhance understanding of this rare cancer.
Novel drug for treatment of Burkitt’s lymphoma
This project hopes to identify alternative therapies for people with Burkitt’s lymphoma who do not respond to standard treatment or relapse.
Unlocking leukaemia’s genetic secrets
Therese Vu is investigating the role of a gene that may play a role in transforming a blood disorder into acute myeloid leukaemia.
Boosting the immune system response
Dr Stephen Mattarollo is investigating how a new vaccine, combined with front-line therapy, Rituximab, improves outcomes for non-Hodgkin lymphoma patients.
Graft v Host disease
To help better understand cGVHD, Katie Lineburg is investigating the cellular processes and immune cells involved in driving the disease.
Targeting stem cells in myeloproliferative disorders
Dr Steven Lane is evaluating a new combination drug therapy for polycythemia vera (PRV).
Double discovery – game changer in quest to cure leukaemia
Researchers at the Peter MacCallum Cancer Centre (Melbourne) have uncovered vital new leads on how to outsmart the deadly disease.
Research project archive
An archive of the blood cancer research projects we’ve funded since 2008.
